Abstract
Ofloxacin (300 mg twice a day) and trimethoprim-sulfamethoxazole (TMP-SMZ) (160 mg trimethoprim and 800 mg sulfamethoxazole twice a day) were given prophylactically to 19 adult patients with acute leukemia undergoing induction chemotherapy. The influence of the two regimens on the bacterial aerobic flora was evaluated. Both of the prophylactic regimens conditioned the aerobic microflora of the patients. Both groups acquired new microorganisms, prevalently gram-positive cocci, but also gram-negative bacteria with the TMP-SMZ regimen. Both treatment groups acquired yeasts.
Publication types
-
Clinical Trial
-
Comparative Study
-
Controlled Clinical Trial
MeSH terms
-
Adult
-
Aged
-
Agranulocytosis / microbiology*
-
Bacteria, Aerobic / drug effects*
-
Drug Combinations / pharmacology
-
Female
-
Humans
-
Intestines / microbiology*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
-
Leukemia, Myeloid, Acute / drug therapy
-
Male
-
Middle Aged
-
Ofloxacin / pharmacology*
-
Random Allocation
-
Sulfamethizole / pharmacology*
-
Sulfathiazoles / pharmacology*
-
Trimethoprim / pharmacology*
Substances
-
Drug Combinations
-
Sulfathiazoles
-
Sulfamethizole
-
trimethoprim sulfamethizole
-
Ofloxacin
-
Trimethoprim